News

Moderna says mRNA flu vaccine sailed through trial, beating standard shot
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
BioSpace13d
Moderna’s Promised mRNA Flu Vaccine Bests Current Standard Shot
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
STAT13dOpinion
The U.S. must invest in mRNA vaccines against pandemic influenza viruses now
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
Moderna (MRNA) Jumps 8.8% on COVID-19 Support from Medical Organizations
Moderna, Inc. (NASDAQ:MRNA) is one of These 10 Stocks Are Making Big Moves. Moderna Inc. jumped by 8.83 percent on Tuesday to ...
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...